A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer
NCT00584857
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Uterine Cancer
Interventions
DRUG:
Paclitaxel ,Carboplatin , Megesterol Acetate
Sponsor
University of Alabama at Birmingham